Drug Type AAV based gene therapy |
Synonyms- |
Target |
Action- |
Mechanism SOD1 replacements(Superoxide dismutase replacements) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | South Korea | 22 Apr 2024 |